Over the past 12 months, $SGMO generated 18 mentions from 2 distinct FinTwit voices, with biotech analyst Adam Feuerstein (@adamfeuerstein) accounting for 17 of those mentions. The first mention appeared on September 11, 2025, while the most recent discussion occurred on June 23, 2026. InvestmentGuru (@investmentguru_) contributed a single mention during this period.

Feuerstein's coverage of Sangamo Therapeutics tracked the company's trajectory toward financial distress. His most recent post from June 23, 2026 stated that "$SGMO ends with bankruptcy sale of its assets. Lilly and Astellas stalking horse bidders." Earlier commentary in April 2026 included cryptic references to the company's declining situation. The mentions span from mid-September 2025 through late June 2026, documenting the biotech company's path through what appears to be a formal bankruptcy and asset sale process.